L-Lysine Imprinted Nanoparticles for Antibody Biorecognition

The aim of this study was to prepare L-lysine-imprinted poly(HEMA-MAAsp) nanoparticles which can be used for the adsorption of IgG from aqueous solutions. L-lysine was complexed with MAAsp and Llysine- imprinted poly(HEMA-MAAsp) nanoparticles were synthesized by miniemulsion polymerization. Also, non-imprinted nanoparticles were synthesized without L-lysine for control purpose. L-lysine-imprinted poly(HEMA-MAAsp) nanoparticles were characterized by means of elemental analysis, Fourier transform infrared spectroscopy (FTIR) and transmission electron microscopy (TEM). When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123456789/3500

Polymeric nanocarriers for expected nanomedicine: Current challenges and future prospects

Polymeric nanocarriers have an increasingly growing potential for clinical applications. The current and future expectation from a polymeric nanocarrier is to exhibit both diagnostic and therapeutic functions. Living organisms are very complex systems and have many challenges for a carrier system such as biocompatibility, biodistribution, side-effects, biological barriers. Therefore, a designed polymeric nanocarrier should possess multifunctional properties to overcome these obstacles towards its target site. However, currently there are few polymeric systems that can be used for both therapy and imaging in clinic studies. In the literature, there are many studies for developing new generation polymeric nanocarriers to obtain future smart and multifunctional nanomedicine. In this review, we discuss the new generation and promising polymeric nanocarriers, which exhibit active targeting, triggered release of contents, and imaging capability for in vivo studies. © The Royal Society of Chemistry 2014